Skip to search formSkip to main contentSkip to account menu

AS-3201

Known as: AS 3201 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ranirestat

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Evaluation of ranirestat for the treatment of diabetic neuropathy
Introduction: Pharmacologic maintenance of normoglycemia in diabetes cannot prevent the eventual complications mainly due to… 
Review
2008
Review
2008
Ranirestat: A Selective Aldose Reductase Inhibitor for Diabetic Sensorimotor Polyneuropathy
Objective: To review the pharmacology, pharmacokinetics, clinical efficacy, and safety of ranirestat, an oral aldose reductase… 
2006
2006
Długoterminowe efekty działania ranirestatu (AS-3201) na funkcję nerwów obwodowych u pacjentów z czuciowo-ruchową polineuropatią cukrzycową
WSTEP . Celem pracy by³o ustalenie, czy ranirestat - inhibitor reduktazy aldozowej, umo?liwia utrzymanie poprawy funkcji nerwow… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)